Is Ozempic or Wegovy Better for Weight Loss?

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic and Wegovy are both semaglutide medications, but one is labeled for diabetes while the other targets weight loss—yet they contain the same active ingredient. Clinical trials show semaglutide users lose 15% of body weight on average over 68 weeks. Understanding the differences helps you choose the right approach for your health.

Understanding Ozempic and Wegovy: Same Drug, Different Purposes

Ozempic and Wegovy are identical in their active ingredient: semaglutide, a GLP-1 receptor agonist that slows digestion and regulates appetite. The key distinction lies in their FDA indication—Ozempic received approval for type 2 diabetes management, while Wegovy was specifically cleared for chronic weight management in adults with obesity or overweight conditions. Despite their different labels, both medications work through the same biological pathway, triggering your body's natural hunger-control systems. Doctors prescribe them based on your primary health condition, but the medication itself produces comparable metabolic effects.

Insurance coverage often differs between the two, with some plans covering Ozempic for diabetes but excluding Wegovy for weight loss alone. This gap in coverage has led many patients to explore compounded semaglutide through providers like PlexusDx, which offers the same active ingredient without insurance requirements. The compounded version is $189/mo month-to-month, or from $149/mo on the 6-month plan, making it accessible to those seeking weight loss support without relying on insurance approval timelines.

Weight Loss Results: What Clinical Trials Show

The STEP clinical trial program, which studied Wegovy's effectiveness, demonstrated that participants on semaglutide lost an average of 15.3% of their starting body weight over 68 weeks—roughly three times more than those receiving placebo. Patients on higher doses saw results ranging from 17% to 22% weight loss, depending on tolerance and adherence. These outcomes held steady for up to two years in extension trials, showing semaglutide's lasting effect when used consistently. Diabetes patients taking Ozempic report similar weight reductions alongside improved blood sugar control, a dual benefit that reinforces semaglutide's metabolic power.

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Cost Comparison: Branded vs. Compounded Semaglutide

Branded Wegovy costs between $900 and $1,400 per month without insurance, placing it out of reach for many seeking weight loss support. Ozempic, when prescribed off-label for weight loss, carries similar pricing but may be partially covered by insurance when coded for diabetes. PlexusDx's compounded semaglutide injection starts at just $189/mo (or $149/mo on the 6-month plan), offering a 75-85% savings compared to branded versions while delivering the same active ingredient from licensed 503A compounding pharmacies. Your dose may need to increase over time, but your price won't—PlexusDx maintains flat pricing across all commitment tiers.

Compounded medications are legal, regulated alternatives that allow patients to access proven therapies without insurance barriers or membership fees. PlexusDx serves all 50 states and accepts HSA/FSA contributions, further reducing out-of-pocket costs. Adding the Precision Peptide Genetic Test for $298 provides personalized insights into your peptide pathways, optimizing your treatment plan.

How to Choose: Factors That Matter for Your Decision

Your choice between Ozempic, Wegovy, and compounded semaglutide depends on your primary health goal, insurance status, budget, and how quickly you need to start treatment. If you have type 2 diabetes and insurance coverage, Ozempic may align with your existing care plan; if weight loss is your primary goal and you have comprehensive coverage, Wegovy offers FDA-approved peace of mind. For uninsured patients or those whose insurance denies weight loss medications, compounded semaglutide from licensed pharmacies provides equivalent clinical results at a fraction of the cost. All three options work through identical mechanisms, so effectiveness is not the deciding factor—access and affordability are.

PlexusDx recommends starting with a consultation to review your medical history, current medications, and weight loss timeline. The Precision Peptide Genetic Test can then identify your genetic strengths within peptide pathways, helping your provider select semaglutide or alternative compounds most likely to succeed for you. This personalized approach increases adherence and reduces the trial-and-error period many patients experience with standard prescribing.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as brand-name Wegovy or Ozempic?

Yes. Compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient and dosing as branded versions. The only differences are manufacturing facility and price—effectiveness and safety profiles remain the same. Clinical outcomes depend on your individual metabolism and adherence, not whether your semaglutide comes from a manufacturer or compounder.

Will my dose increase over time, and will my price increase too?

Your dose may increase as your body adjusts to semaglutide, a common part of GLP-1 therapy called titration. PlexusDx maintains flat monthly pricing at $189 regardless of dose level—your price won't change even as your dose goes up. This transparency means no surprise costs as your treatment progresses.

How do I know if semaglutide is right for my genetics?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO (rs9939609)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I use my HSA or FSA to pay for compounded semaglutide?

Yes. PlexusDx-provided semaglutide qualifies for HSA and FSA contributions in most cases, reducing your actual out-of-pocket cost beyond the $189 monthly base price. Check your specific account rules, but most plans treat compounded semaglutide as an eligible medical expense.

What common side effects should I expect with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Wegovy Weight Loss Pills

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.